Emmaus Life Sciences, Inc. (EMMAW) and trades at $0.07. The 52-week range is 0.0725-0.0725.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.5, Earnings Per Share (EPS) of $-0.12, annual revenue of $12.45M.
The stock has a beta of 0.00, operates in the Healthcare sector.
